This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

HIV distal sensory polyneuropathy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • estimated that 15% to 62% of patients with human immunodeficiency virus infection suffer from distal sensory polyneuropathy (DSP):
    • results either from HIV-associated immune and viral protein-mediated neurotoxicity or
    • from neurotoxic dideoxynucleoside antiretroviral therapy (ARV)
  • severe, chronic pain from HIV associated DSP
    • can have a profound negative effect on the physical, emotional, and functional health of the patient with HIV/AIDS
  • treatment options:
    • symptomatic
      • there is evidence regarding the efficacy of a high-concentration capsaicin patch reducing pain in patients with HIV neuropathy

Reference:

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.